About eNeura
eNeura is a company based in Baltimore (United States) founded in 2000.. eNeura has raised $70.51 million across 18 funding rounds from investors including Orthofix, Camden Partners and NEA. The company has 17 employees as of December 31, 2022. eNeura offers products and services including sTMS Device and SAVI Smart Diary. eNeura operates in a competitive market with competitors including ElectroCore, ShiraTronics, Salvia BioElectronics, Cefaly and Zosano Pharma, among others.
- Headquarter Baltimore, United States
- Employees 17 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Eneura, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$70.51 M (USD)
in 18 rounds
-
Latest Funding Round
$511.04 K (USD), Series D
Feb 21, 2020
-
Investors
Orthofix
& 4 more
-
Employee Count
17
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of eNeura
eNeura offers a comprehensive portfolio of products and services, including sTMS Device and SAVI Smart Diary. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive device that treats and prevents migraines using magnetic pulses.
App that automatically records and monitors migraine treatment history.
Funding Insights of eNeura
eNeura has successfully raised a total of $70.51M across 18 strategic funding rounds. The most recent funding activity was a Series D round of $511.04 thousand completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 18
- Last Round Series D — $511,036
-
First Round
First Round
(11 Jan 2010)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2020 | Amount | Series D - eNeura | Valuation |
investors |
|
| Nov, 2019 | Amount | Debt – Conventional - eNeura | Valuation |
investors |
|
| Mar, 2019 | Amount | Series D - eNeura | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in eNeura
eNeura has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Orthofix, Camden Partners and NEA. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth equity investments are made in lower middle market companies.
|
Founded Year | Domain | Location | |
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
Investments are made in US life sciences and energy companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by eNeura
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - eNeura
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Eneura Comparisons
Competitors of eNeura
eNeura operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ElectroCore, ShiraTronics, Salvia BioElectronics, Cefaly and Zosano Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Non-invasive vagus nerve stimulation devices are developed for headache treatments.
|
|
| domain | founded_year | HQ Location |
Neuromodulation devices for migraine and chronic disease treatment are developed.
|
|
| domain | founded_year | HQ Location |
Bioelectronic solutions for migraines and neurological disorders are developed.
|
|
| domain | founded_year | HQ Location |
Neurostimulation devices for migraine and headache treatment are provided.
|
|
| domain | founded_year | HQ Location |
Develops innovative transdermal drug delivery technologies for various therapeutic applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Eneura
Frequently Asked Questions about eNeura
When was eNeura founded?
eNeura was founded in 2000 and raised its 1st funding round 10 years after it was founded.
Where is eNeura located?
eNeura is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
Is eNeura a funded company?
eNeura is a funded company, having raised a total of $70.51M across 18 funding rounds to date. The company's 1st funding round was a Series D of $200K, raised on Jan 11, 2010.
How many employees does eNeura have?
As of Dec 31, 2022, the latest employee count at eNeura is 17.
What does eNeura do?
eNeura was founded in 2000 and is headquartered in Baltimore, United States. Portable, non-invasive transcranial magnetic stimulation devices are developed by the company for migraine pain relief. An FDA-approved prescription device is provided, allowing patients to self-administer treatments as needed. Operations focus on neuromodulation technology within the medical device sector, targeting chronic headache management.
Who are the top competitors of eNeura?
eNeura's top competitors include Salvia BioElectronics, ShiraTronics and ElectroCore.
What products or services does eNeura offer?
eNeura offers sTMS Device and SAVI Smart Diary.
Who are eNeura's investors?
eNeura has 5 investors. Key investors include Orthofix, Camden Partners, NEA, Technology Partners, and Domain Associates.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.